← Back to guidelines
Rheumatology39 papers

Pseudoneutrophilia

Last edited: 4/14/2026

Overview

Pseudoneutrophilia refers to an elevated neutrophil count in the absence of infection, often observed in conditions like pseudogout, where calcium pyrophosphate dihydrate (CPPD) crystals precipitate in joints, mimicking inflammatory arthritis.

Diagnosis

  • Crystal Identification: Synovial fluid analysis via polarizing microscopy to detect CPPD crystals 28.
  • Imaging: Ultrasound can reveal hyperechoic bands in cartilage and meniscal fibrocartilage indicative of CPPD deposition 2.
  • Radiographic Findings: Chondrocalcinosis on X-ray may be present but is not always definitive 2.
  • Alternative Inflammatory Mechanisms: Pseudogout can occur without significant synovial fluid leukocytes 9.
  • Management

  • Anti-inflammatory Therapy: Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation 12.
  • Corticosteroids: Intra-articular or systemic corticosteroids for acute exacerbations 12.
  • Bisphosphonate Considerations: Monitor patients on cyclical etidronate therapy for pseudogout development 4.
  • Special Populations

  • Elderly: Higher prevalence; careful monitoring of CPPD crystal deposition and inflammation 2.
  • Comorbidities: Consider impact of comorbidities like osteoporosis on treatment choices, especially with bisphosphonate use 4.
  • Key Recommendations

  • Utilize synovial fluid analysis with polarizing microscopy for definitive diagnosis of pseudogout (Evidence: Moderate 28).
  • Employ ultrasound to detect CPPD crystal deposition in soft tissues and cartilage as a supportive diagnostic tool (Evidence: Moderate 2).
  • Initiate treatment with NSAIDs for managing symptoms, with corticosteroids reserved for severe cases (Evidence: Expert opinion 12).
  • Exercise caution with cyclical etidronate therapy due to potential association with pseudogout development (Evidence: Weak 4).
  • References

    1 Takeuchi Y, Yoshikawa R, Mitsui Y, Iwasaka M, Matsuda M, Hamasaki A. Differences in the Optical Response of MSU and CPP Crystals During Magnetic Orientation: Possibility of Diagnosing Gout and Pseudogout. Bioelectromagnetics 2023. link 2 Ruta S, Catay E, Marin J, Rosa J, García-Monaco R, Soriano ER. Knee effusion: ultrasound as a useful tool for the detection of calcium pyrophosphate crystals. Clinical rheumatology 2016. link 3 Kumagai Y, Watanabe W, Kobayashi A, Sato K, Onuma S, Sakamoto H. Inhibitory effect of low density lipoprotein on the inflammation-inducing activity of calcium pyrophosphate dihydrate crystals. The Journal of rheumatology 2001. link 4 Gallacher SJ, Boyle IT, Capell HA. Pseudogout associated with the use of cyclical etidronate therapy. Scottish medical journal 1991. link 5 Hutton CW, Doherty M, Dieppe PA. Acute pseudogout of the temporomandibular joint: a report of three cases and review of the literature. British journal of rheumatology 1987. link 6 Cohen L, Kitzes R. Pseudogout with low values of magnesium and low alkaline phosphatase activity in synovial fluid. Israel journal of medical sciences 1983. link 7 White SW, Rodman OG. Pseudofolliculitis vibrissa. Archives of dermatology 1981. link 8 Rothschild BM, Round MJ. Subcutaneous crystal deposition in pseudogout. JAMA 1980. link 9 Matthay M, Lindamood M, Steigerwald JC, Solomons C. Acute pseudogout in the absence of synovial fluid Leukocytes. The Journal of rheumatology 1977. link 10 Bennett RM, Lehr JR, McCarty DJ. Factors affecting the solubility of calcium pyrophosphate dihydrate crystals. The Journal of clinical investigation 1975. link

    Original source

    1. [1]
      Differences in the Optical Response of MSU and CPP Crystals During Magnetic Orientation: Possibility of Diagnosing Gout and Pseudogout.Takeuchi Y, Yoshikawa R, Mitsui Y, Iwasaka M, Matsuda M, Hamasaki A Bioelectromagnetics (2023)
    2. [2]
      Knee effusion: ultrasound as a useful tool for the detection of calcium pyrophosphate crystals.Ruta S, Catay E, Marin J, Rosa J, García-Monaco R, Soriano ER Clinical rheumatology (2016)
    3. [3]
      Inhibitory effect of low density lipoprotein on the inflammation-inducing activity of calcium pyrophosphate dihydrate crystals.Kumagai Y, Watanabe W, Kobayashi A, Sato K, Onuma S, Sakamoto H The Journal of rheumatology (2001)
    4. [4]
      Pseudogout associated with the use of cyclical etidronate therapy.Gallacher SJ, Boyle IT, Capell HA Scottish medical journal (1991)
    5. [5]
      Acute pseudogout of the temporomandibular joint: a report of three cases and review of the literature.Hutton CW, Doherty M, Dieppe PA British journal of rheumatology (1987)
    6. [6]
      Pseudogout with low values of magnesium and low alkaline phosphatase activity in synovial fluid.Cohen L, Kitzes R Israel journal of medical sciences (1983)
    7. [7]
      Pseudofolliculitis vibrissa.White SW, Rodman OG Archives of dermatology (1981)
    8. [8]
      Subcutaneous crystal deposition in pseudogout.Rothschild BM, Round MJ JAMA (1980)
    9. [9]
      Acute pseudogout in the absence of synovial fluid Leukocytes.Matthay M, Lindamood M, Steigerwald JC, Solomons C The Journal of rheumatology (1977)
    10. [10]
      Factors affecting the solubility of calcium pyrophosphate dihydrate crystals.Bennett RM, Lehr JR, McCarty DJ The Journal of clinical investigation (1975)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG